Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Background: Among patients prescribed long-term opioid therapy (LTOT) for chronic pain, no study has yet examined how clinicians respond to evidence of illicit drug use and whether the decision to discontinue opioids is influenced by a patient’s race. Methods: Among outpatients of black and white race initiating LTOT through the VA between 2000 and 2010, we reviewed electronic medical records to determine whether opioids were discontinued within 60 days of a positive urine drug test. Logistic regression was used to examine differences by race. Results: Among 15,366 patients of black (48.1%) or white (51.9%) race initiating LTOT from 2000–2010, 20.5% (25.5% of blacks vs. 15.8% of whites, P <. 001) received a urine drug test within the first 6 months of treatment; 13.8% tested positive for cannabis and 17.4% for cocaine. LTOT was discontinued in 11.4% of patients who tested positive for cannabis and in 13.1% of those who tested positive for cocaine. Among patients testing positive for cannabis, blacks were 2.1 times more likely than whites to have LTOT discontinued (adjusted odds ratio [AOR] 2.06, 95% confidence interval [CI] 1.04–4.08). Among patients testing positive for cocaine, blacks were 3.3 times more likely than whites to have LTOT discontinued (AOR 3.30, CI 1.28–8.53). Conclusions: Among patients testing positive for illicit drug use while receiving LTOT, clinicians are substantially more likely to discontinue opioids when the patient is black. A more universal approach to administering and responding to urine drug testing is urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697 · cited 5×
“…potential, we believe that the safest and most judicious way forward is for clinicians to adhere to the latest guidelines from the CDC, which recommend that urine drug testing be administered to all patients prior to opioid initiation and then at least annually thereafter (Dowell et al., 2016).”
InfluentialIncreases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194
Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain
Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., Donovan, M. I., Fishbain, D. A., Foley, K. M., Fudin, J., et al. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2008.10.008 · Cited by 2,192
Increases in drug and opioid overdose deaths — United States, 2000–2014
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6450a3 · Cited by 1,859
Seal, K. H., Shi, Y., Cohen, G., Cohen, B. E., Maguen, S., Krebs, E. E., & Neylan, T. C. (2012) · JAMA · doi:10.1001/jama.2012.234 · Cited by 515
Prejudice, clinical uncertainty and stereotyping as sources of health disparities
Balsa, A. I., & McGuire, T. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00098-x · Cited by 333
Mennis, J., & Stahler, G. J. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.12.007 · Cited by 198 · cited 1×
“Despite these limitations, we believe our findings should be considered in the context of a substantial body of literature that shows that blacks often face disparities in care (Abdus et al., 2015; Asch et al., 2006; Balsa and McGuire, 2003; Guerrero et al., 2013; Mennis and Stahler, 2016; Sahker et al., 2015), includ…”
Disparities in completion of substance abuse treatment between and within racial and ethnic groups
Guerrero, E. G., Marsh, J. C., Duan, L., Oh, C., Perron, B., & Lee, B. (2013) · Health Services Research · doi:10.1111/1475-6773.12031 · Cited by 168 · cited 1×
“…body of literature that shows that blacks often face disparities in care (Abdus et al., 2015; Asch et al., 2006; Balsa and McGuire, 2003; Guerrero et al., 2013; Mennis and Stahler, 2016; Sahker et al., 2015), including in relation to opioid prescribing and treatment (Becker et al.,…”
. Towards a combined prognostic index for survival in HIV infection: the role of non-HIV biomarkers.
Justice, A., McGinnis, K., Skanderson, M., Chang, C., Gibert, C., Goetz, M., Rimland, D., Rodriguez‐Barradas, M., Oursler, K., Brown, S., et al. (2010) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00757.x · Cited by 159
Cited by
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7103a1 · Cited by 1,886
Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Tsai, A. C., Kiang, M. V., Barnett, M. L., Beletsky, L., Keyes, K. M., McGinty, E. E., Smith, L. R., Strathdee, S. A., Wakeman, S. E., & Venkataramani, A. S. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002969 · Cited by 437
Trends and Rapidity of Dose Tapering Among Patients Prescribed Long-term Opioid Therapy, 2008-2017
Fenton, J. J., Agnoli, A. L., Xing, G., Hang, L., Altan, A. E., Tancredi, D. J., Jerant, A., & Magnan, E. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.16271 · Cited by 97
Disparities in the provision of perinatal care based on patient race in the United States
Byrn, M. A., Buys, E. A., Mujahid, M., & Madsen, K. (2023) · Birth · doi:10.1111/birt.12717 · Cited by 17
Metadata
- Authors
- Gaither, J. R., Gordon, K., Crystal, S., Edelman, E. J., Kerns, R. D., Justice, A. C., Fiellin, D. A., & Becker, W. C.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 192
- Pages
- 371-376
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2887815755
- Cited by
- 94
- References
- 10
- FWCI
- 7.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2018.05.033
- The paper
- Gaither, J. R., Gordon, K., Crystal, S., Edelman, E. J., Kerns, R. D., Justice, A. C., Fiellin, D. A., & Becker, W. C. (2018). Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2018.05.033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.